Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins.
about
Nocardia brasiliensis induces formation of foamy macrophages and dendritic cells in vitro and in vivoEffects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicansCandida albicans and Pseudomonas aeruginosa Interaction, with Focus on the Role of EicosanoidsPotential Targets for Antifungal Drug Discovery Based on Growth and Virulence in Candida albicansProduction of cross-kingdom oxylipins by pathogenic fungi: An update on their role in development and pathogenicityPotential Antifungal Targets against a Candida Biofilm Based on an Enzyme in the Arachidonic Acid Cascade-A ReviewThe presence of 3-hydroxy oxylipins in pathogenic microbesTransient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells.Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13Yeasts in the gut: from commensals to infectious agents.Gut Colonization by Candida albicans Inhibits the Induction of Humoral Immune Tolerance to Dietary Antigen in BALB/c MiceParadoxical roles of alveolar macrophages in the host response to Cryptococcus neoformans.A nutrient-regulated, dual localization phospholipase A(2) in the symbiotic fungus Tuber borchii.Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.Modulation of morphogenesis in Candida albicans by various small molecules.The anti-mitochondrial antifungal assay for the discovery and development of new drugs.Magnificent seven: roles of G protein-coupled receptors in extracellular sensing in fungi.Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production.The emerging world of the fungal microbiome.Modulation of post-antibiotic bacterial community reassembly and host response by Candida albicans.Potential contribution of fungal infection and colonization to the development of allergy.Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndromeConjugated linoleic acid inhibits hyphal growth in Candida albicans by modulating Ras1p cellular levels and downregulating TEC1 expression.The mycobiota: interactions between commensal fungi and the host immune system.Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.Richness and diversity of mammalian fungal communities shape innate and adaptive immunity in health and disease.The phospholipase B homolog Plb1 is a mediator of osmotic stress response and of nutrient-dependent repression of sexual differentiation in the fission yeast Schizosaccharomyces pombe.Cryptococcal lipid metabolism: phospholipase B1 is implicated in transcellular metabolism of macrophage-derived lipids.Immune Interactions with Pathogenic and Commensal Fungi: A Two-Way StreetBiosynthesis and immunogenicity of glucosylceramide in Cryptococcus neoformans and other human pathogens.Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the "red complex", a prototype polybacterial pathogenic consortium in periodontitis.Candida parapsilosis produces prostaglandins from exogenous arachidonic acid and OLE2 is not required for their synthesis.Gene expression in HL60 granulocytoids and human polymorphonuclear leukocytes exposed to Candida albicans.Arachidonic acid metabolites in pathogenic yeasts.The 'microflora hypothesis' of allergic diseases.Growth and adherence of Staphylococcus aureus were enhanced through the PGE2 produced by the activated COX-2/PGE2 pathway of infected oral epithelial cells.Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy.Phospholipase A2 and phospholipase B activities in fungiRole of oxylipins and other lipid mediators in fungal pathogenesis.Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.
P2860
Q21090611-F8BDD9E6-D26C-4305-9A12-C8A76B06F1E0Q24630887-466859BC-2F4E-4029-B426-05E9A19CE512Q26767229-8CB9D55F-AAB8-4C13-AD6E-CDCBC34BBB62Q26801524-DCB5D932-4C1F-48F5-A272-CAE95E0CE8ECQ28075094-257040BA-4836-4F95-8661-741C0E9B5481Q28077611-13A06BA8-C199-4EA6-8519-58C8F658F3A1Q28395036-00575CD8-1BC0-432C-9118-58D7A2D08E47Q33556794-0843A27B-BB46-403A-B558-348C029AC2D1Q33557513-F684E318-F8AC-4785-A092-479BB4E64F0CQ33579140-3123E238-3A46-4E86-9864-940DBD0DFB6AQ33665942-945BB27C-6F55-46DC-BBA1-B839051AEDDBQ33673568-4DABBCD9-86E5-4AC6-B3A2-E86E29EFA7CAQ34082264-603E82C0-0649-47F6-A355-4D7BA95F0BD3Q34122405-64F6F886-286D-4BB8-99D5-45E39FFB3F84Q34189952-9E9787A6-0368-4328-8174-FF833AE7CB4AQ34278041-3C94EF78-AB57-421F-A02F-8D4673BCF105Q34386803-2E1A7758-932C-4F40-8AD2-27BC427A1339Q34713346-0576997C-A77C-4DE0-94C1-6E2B381EDB41Q34727901-CB21C00D-7D9B-4FFA-97E0-DBD72E78E928Q34813691-10DCE036-2FC7-4B12-9739-AB43B4A58E69Q34977170-574AC338-B94D-454E-953B-59E04192C6EBQ35061903-7CE84E9A-5DB0-48CE-A71D-8CBAA58A82F8Q35080843-31915851-0BE8-4F9E-899A-CFCC6224DB47Q35096262-87693786-F93B-496C-926A-BED00DD389D2Q35139747-12C7C4C0-5F40-446A-B98C-70CF3F7D59A3Q35278095-DE727474-3542-488D-9F81-38C0F70F2F26Q35569176-ABC3CA26-43C0-4002-B727-1B98F4B3A237Q35641047-9992E1B4-C8DE-4BC7-89E9-EF2606ABAF32Q35847333-ECD9DFB4-5A29-4227-8CB1-FE617A05F6B8Q36095320-3DCAAC65-455C-40D1-9B2A-4C1252F8ACABQ36107786-B8F46B76-2BBA-45EB-9965-A492AAA304ACQ36155016-685DE980-B208-41FC-A16A-E704856B5EB4Q36227075-01217EA8-F5A3-451A-AC03-1AFD5973C0EBQ36329171-8D7C2977-C551-469C-86F0-C046738DD682Q36360555-38530DCB-AF8E-49CF-9015-A7238DE0E03EQ36363166-DB32F9F9-3B58-4012-B5E0-D55CC598635AQ36569737-7130218A-3059-4D52-B815-C3A295A8BC0EQ36643090-B9F70766-E288-4D4B-A03A-1079C93D4306Q36895701-4B5F279A-6DCE-45E8-8D28-B7E819576762Q37123421-0850EC68-D88B-4D68-B4FA-74EBAB2112C9
P2860
Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pathogenic yeasts Cryptococcus ...... munomodulatory prostaglandins.
@ast
Pathogenic yeasts Cryptococcus ...... munomodulatory prostaglandins.
@en
Pathogenic yeasts Cryptococcus ...... munomodulatory prostaglandins.
@nl
type
label
Pathogenic yeasts Cryptococcus ...... munomodulatory prostaglandins.
@ast
Pathogenic yeasts Cryptococcus ...... munomodulatory prostaglandins.
@en
Pathogenic yeasts Cryptococcus ...... munomodulatory prostaglandins.
@nl
prefLabel
Pathogenic yeasts Cryptococcus ...... munomodulatory prostaglandins.
@ast
Pathogenic yeasts Cryptococcus ...... munomodulatory prostaglandins.
@en
Pathogenic yeasts Cryptococcus ...... munomodulatory prostaglandins.
@nl
P2093
P2860
P1476
Pathogenic yeasts Cryptococcus ...... munomodulatory prostaglandins.
@en
P2093
G B Huffnagle
M C Noverr
M J Coffey
P2860
P304
P356
10.1128/IAI.69.5.2957-2963.2001
P407
P577
2001-05-01T00:00:00Z